NCT02112526 2024-12-20Acalabrutinib (ACP-196), a Btk Inhibitor, for Treatment of de Novo Activated B-cell (ABC) Subtype of Diffuse Large B-Cell LymphomaAcerta Pharma BVPhase 1 Completed21 enrolled 11 charts
NCT02658968 2024-01-16Study of Betalutin for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma (LYMRIT-37-05)Nordic NanovectorPhase 1 Completed18 enrolled 16 charts
NCT00079716 2014-12-18Study of SGN-40 in Patients With Refractory or Recurrent Multiple MyelomaSeagen Inc.Phase 1 Completed44 enrolled
NCT00103779 2014-12-18A Safety Study of SGN-40 in Patients With Non-Hodgkin's LymphomaSeagen Inc.Phase 1 Completed50 enrolled
NCT00525447 2014-10-09Study of SGN-40, Lenalidomide, and Dexamethasone in Patients With Multiple MyelomaSeagen Inc.Phase 1 Completed36 enrolled